Brief: Tissue Regenix Group H1 Revenue Rises 19%

Tissue Regenix

05/09/2023 07:28

Sept 5 (Reuters) - Tissue Regenix Group PLC  TRX.L :
    * H1 REVENUE ROSE 19 PERCENT TO 14.1 MILLION USD
    * H1 ADJUSTED EBITDA 400,000 USD VERSUS 500,000 USD LOSS
YEAR AGO
    * HY GROUP REVENUES INCREASED BY 19% TO USD14.1 MILLION
    * THERE ARE LINGERING ISSUES IN SUPPLY CHAIN, WITH LABOUR
DISRUPTIONS AND WIDER ECONOMIC UNCERTAINTIES
    * EXPECT 2023 TO BE OUR FIRST FULL YEAR OF PROFITABILITY ON
AN
ADJUSTED EBITDA BASIS

Source text for Eikon:  ID:nRSE3411La 
Further company coverage:  TRX.L 

 ((Reuters.Briefs@thomsonreuters.com;;))